NewAmsterdam Pharma Company N.V. (NAMS)

NAMS Revenue

NewAmsterdam Pharma Company had revenue of $2.28M in the quarter ending June 30, 2024, with 32.73% growth. This brings the company's revenue in the last twelve months to $7.42M, down -32.30% year-over-year. In the year 2023, NewAmsterdam Pharma Company had annual revenue of $14.09M, down -86.28%.

• Revenue (ttm): $7.42M
• Revenue Growth: -32.30%
• P/S Ratio: 211.39
• Revenue / Employee: $256,000
• Employees: 29
• Market Cap: 1.62B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	14.09M	-88.60M	-86.28%
Dec 31, 2022	102.69M	-	-
Dec 31, 2021	-	-	-
Dec 31, 2020	-	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.